Portal de Periódicos da CAPES

Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging

2022; Elsevier BV; Volume: 206; Linguagem: Inglês

10.1016/j.mad.2022.111711

1872-6216

Monica Barone, Federica D’Amico, Simone Rampelli, Patrizia Brigidi, Silvia Turroni,

Diet and metabolism studies

The gut microbiome is undoubtedly a key modulator of human health, which can promote or impair homeostasis throughout life. This is even more relevant in old age, when there is a gradual loss of function in multiple organ systems, related to growth, metabolism, and immunity. Several studies have described changes in the gut microbiome across age groups up to the extreme limits of lifespan, including maladaptations that occur in the context of age-related conditions, such as frailty, neurodegenerative diseases, and cardiometabolic diseases. The gut microbiome can also interact bi-directionally with anti-age-related disease therapies, being affected and in turn influencing their efficacy. In this framework, the development of integrated microbiome-based intervention strategies, aimed at favoring a eubiotic configuration and trajectory, could therefore represent an innovative approach for the promotion of healthy aging and the achievement of longevity.